3M Critical and Chronic Care Solutions today announces the launch of its new 3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Port Dressing, designed for patients with implanted port devices under their skin and connected to a catheter for the purpose of central venous infusions. This announcement coincides with the Oncology Nursing Society (ONS) 40th Annual Congress show in Orlando, Fla.
The new offering combines, for the first time, a transparent, port-site dressing with a separate, compatible antimicrobial CHG gel pad device that’s also clear and designed specifically for ports. This allows for continuous, unobstructed observation of the I.V. insertion site, even in the presence of saline, blood and exudates.
In addition, an adhesive-free window on the dressing ensures that it doesn’t stick to the needle or patient during dressing removal. And the CHG gel pad not only provides immediate and continuous antimicrobial protection, but it is designed to conform around the needle at the insertion site. Because the cover dressing and CHG gel pad accommodate a variety of non-coring Huber needles, only one size is needed, making it a versatile option. Both the dressing and pad flex with patient movement and can be worn for up to seven days.
“In the fight against infection, the dressing really matters, and too often patients with implanted venous ports are left with uncomfortable, ill-fitting dressings that don’t do enough to ward off contaminants,” said Leslie McDonnell, vice president of global marketing, 3M Critical & Chronic Care Solutions. “Clinicians have given our Tegaderm™ CHG I.V. Port Dressing 90 percent or better satisfaction ratings versus competitor products when it comes to overall performance, patient comfort, wear time, ease of removal and the ability to visualize the insertion area. This new offering, designed especially for patients with implanted venous ports, provides a barrier against several common pathogens known to cause catheter-related bloodstream infections.”
The Tegaderm™ CHG I.V. Port Dressing (3M catalog number 1665) is immediately available and sold 25 dressings to a box, four boxes to a case. The Centers for Medicare and Medicaid Services have assigned the product Healthcare Common Procedure Coding System (HCPCS) code A6268. A version of the product containing the dressing but not the CHG gel pad device will be made available later this summer.
To learn more, visit 3M.com/TegadermIVPortDressings or contact your 3M Critical & Chronic Care Solutions representative. If you do not have a representative, you can also call the 3M Health Care Customer Helpline at (800) 228-3957. Outside of the United States, contact your local 3M subsidiary.
About 3M Health Care
3M Health Care offers solutions in the medical, oral care, drug delivery, food safety and health information markets. We have an unparalleled ability to connect people, insights, science and technology to think beyond today, solve problems, and make better health possible. Our culture of collaboration empowers us to discover and deliver practical, proven solutions that enable our customers to protect and improve the health of people around the world. Learn more at www.3MHealthcare.com.
About 3M
At 3M, we apply science in collaborative ways to improve lives daily. With $32 billion in sales, our 90,000 employees connect with customers all around the world. Learn more about 3M’s creative solutions to the world’s problems at www.3M.com or on Twitter @3M or @3MNewsroom.
For 3MAaron Berstler, 651-789-1264Kohnstamm Communicationsaaron@kohnstamm.com
